NPI registry status
Active
2026 NPPES data Hospitalist Physician NPI 1073781621 MD, PHD
Verify on CMS → Daniel Lin, MD, PHD
Hospitalist Physician in Philadelphia, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 16,938 in Hospitalist Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
13K
Medicare Part D claims · 679 beneficiaries · Hospitalist Physician avg: 888
Generic prescribing
90%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$455.57
28 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daniel Lin, MD, PHD filed 12,910 Medicare Part D claims in 2023 as a Hospitalist Physician in Philadelphia, Pennsylvania, prescribing 90% generic.
- 13K
- Part D claims, 2023
- 90%
- generic prescribing
- $455.57
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Lin, MD, PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
12,910 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Daniel Lin, MD, PHD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Lin, MD, PHD?
Quality data not reportedPrimary specialty
Hospitalist Physician
Medicare Part D claims
12,910 15× vs specialty avg
Specialty distribution in Pennsylvania
How Hospitalist Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hospitalist Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Lin, MD, PHD appears in the CMS NPPES registry as a Hospitalist Physician provider holding MD, PHD credentials at 3353 COTTMAN AVE, Philadelphia, PA, 19149, with a listed phone of (215) 332-4410. NPI 1073781621 was issued on 02/18/2008.
Medicare Part D records for calendar year 2023 show 12,910 prescription claims written by this provider, covering 679 Medicare beneficiaries and totaling roughly $823K in drug spend, split 8% brand-name and 90% generic by claim count, with an opioid prescribing rate of 0.6%.
Hospitalist Physician is a mid-sized specialty nationwide, with 16,938 enrolled providers across 54 states and an average of 888 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1073781621 |
|---|---|
| Specialty | Hospitalist Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 02/18/2008 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Lin, MD, PHD. Source: openpaymentsdata.cms.gov.
Total received
$456
Largest payer
Gilead Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Daniel Lin, MD, PHD. To verify Daniel Lin, MD, PHD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Daniel Lin, MD, PHD - brand share 8.0%
Hospitalist Physician average
8% brand-name claims vs 90% generic, on 12,910 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
12,910
Total Claims
$823K
Total Drug Cost
679
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 23,097
- Total Day Supply
- 651,867
- Brand vs Generic
- 8% brand / 90% generic
- Brand Drug Cost
- $607K
- Generic Drug Cost
- $212K
- Opioid Claims
- 72 (0.6% rate)
- Antibiotic Claims
- 570
Patient Demographics
- Average Patient Age
- 71.7 years
- Avg HCC Risk Score
- 1.05
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 35, 65-74: 459, 75-84: 138, 85+: 47
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Lin, MD, PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Simvastatin
Simvastatin
685 claims
- Atorvastatin Calcium
Atorvastatin Calcium
660 claims
- Amlodipine Besylate
Amlodipine Besylate
647 claims
- Losartan Potassium
Losartan Potassium
489 claims
- Tamsulosin Hcl
Tamsulosin Hcl
418 claims
- Metformin Hcl
Metformin Hcl
394 claims
- Lisinopril
Lisinopril
360 claims
- Diclofenac Sodium
Diclofenac Sodium
331 claims
| Drug | Claims |
|---|---|
| Simvastatin | 685 |
| Atorvastatin Calcium | 660 |
| Amlodipine Besylate | 647 |
| Losartan Potassium | 489 |
| Tamsulosin Hcl | 418 |
| Metformin Hcl | 394 |
| Lisinopril | 360 |
| Diclofenac Sodium | 331 |
| Alendronate Sodium | 308 |
| Metformin Hcl Er Metformin Hcl | 301 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hospitalist Physician Overview
How Daniel Lin, MD, PHD fits within the Hospitalist Physician landscape nationally.
16,938
Hospitalist Physician Providers in US
54
States with Hospitalist Physician
888
Avg Claims per Provider
Daniel Lin, MD, PHD's 12,910 claims are above the specialty average of 888.
Nearby Hospitalist Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Lin.
Dr. Mohamed Abdelnaby
MD
Allentown, PA
Dr. Waheed Abdul
MD
Wilkes Barre, PA
Dr. Fnu Abhishek
MD
Greensburg, PA
Dr. Andrew Abouzeid
DO
Hershey, PA
Dr. Bharat Adroja
M.D.
Lock Haven, PA
Compare Hospitalist Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hospitalist Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is Daniel Lin, MD, PHD's specialty? ▼
Daniel Lin, MD, PHD specializes in Hospitalist Physician and practices in Philadelphia, Pennsylvania. Credentials: MD, PHD.
How much does Daniel Lin, MD, PHD prescribe under Medicare Part D? ▼
In 2023, Daniel Lin, MD, PHD wrote 12,910 Medicare Part D claims totaling $823K in drug costs for 679 beneficiaries.
Where is Daniel Lin, MD, PHD located? ▼
Daniel Lin, MD, PHD is located at 3353 COTTMAN AVE, Philadelphia, PA, 19149. Phone: (215) 332-4410.
What is Daniel Lin, MD, PHD's NPI number? ▼
Daniel Lin, MD, PHD's National Provider Identifier (NPI) is 1073781621, issued on 02/18/2008.
Does Daniel Lin, MD, PHD prescribe more brand-name or generic drugs? ▼
Daniel Lin, MD, PHD's prescribing is 8% brand-name and 90% generic drugs by claim count, with $607K in brand drug costs.
Does Daniel Lin, MD, PHD prescribe opioids? ▼
Yes, Daniel Lin, MD, PHD had 72 opioid claims in 2023 with an opioid prescribing rate of 0.6%.
How many Hospitalist Physician providers are there in the US? ▼
There are 16,938 Hospitalist Physician providers across 54 states in the US. The average Hospitalist Physician provider writes 888 Medicare Part D claims per year.
What drugs does Daniel Lin, MD, PHD prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Lin, MD, PHD's most frequently prescribed drugs include Simvastatin, Atorvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Lin, MD, PHD accept Medicare? ▼
Daniel Lin, MD, PHD appears in CMS Medicare data with 12,910 Part D claims and 679 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Lin, MD, PHD's credentials? ▼
Daniel Lin, MD, PHD's NPI is 1073781621 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.